Expanding Dynamic Vergence Testing to Diverse Industries

Publication ID: 24-11857258_0002_PTD
Published: November 07, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Expanding Dynamic Vergence Testing to Diverse Industries,” Published Technical Disclosure No. 24-11857258_0002_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857258_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,258.

Summary of the Inventive Concept

This inventive concept leverages the core technology of dynamic vergence testing, originally designed for clinical objective testing of vergence dysfunction, to address novel applications in warehouse logistics, autonomous vehicles, athletic performance, anxiety disorders, and pilot training.

Background and Problem Solved

The original patent's dynamic vergence testing platform, including a 3D head-mounted display system with integrated eye tracking technology, was primarily focused on diagnosing and treating vergence dysfunction. However, its capabilities have broader implications for various industries where visual acuity, reaction time, and situational awareness are crucial. This inventive concept tackles the limitations of the original patent by applying its core technology to these new, high-impact areas.

Detailed Description of the Inventive Concept

The inventive concept involves adapting the dynamic vergence testing platform to optimize warehouse logistics by improving worker productivity and reducing errors. In autonomous vehicles, it enhances safety and navigation by training vehicles to respond to complex visual stimuli. For athletic performance, it improves reaction time and visual acuity. In treating anxiety disorders, it reduces symptoms and improves cognitive function. Finally, in pilot training, it enhances situational awareness and reduces errors. Each application leverages the platform's ability to simulate real-world scenarios, track eye movements, and provide personalized feedback.

Novelty and Inventive Step

The new claims introduce novel applications of the dynamic vergence testing platform, expanding its scope beyond clinical testing to diverse industries. This inventive concept's non-obviousness lies in its ability to adapt the original technology to address specific challenges in each new application area, resulting in unique solutions that improve performance, safety, and efficiency.

Alternative Embodiments and Variations

Alternative embodiments may include using augmented reality instead of 3D head-mounted displays, incorporating artificial intelligence to personalize feedback, or integrating the platform with existing training systems. Variations could also involve applying the technology to other industries, such as healthcare, education, or gaming.

Potential Commercial Applications and Market

This inventive concept has significant commercial potential in various industries, including logistics, automotive, sports, healthcare, and aviation. The market for dynamic vergence testing platforms is expected to grow as companies seek innovative solutions to improve performance, safety, and efficiency. The adaptability of this technology to diverse industries positions it for widespread adoption and significant revenue generation.

CPC Classifications

SectionClassGroup
A A61 A61B3/113
A A61 A61B3/0041
G G02 G02B27/0093
G G02 G02B27/017

Original Patent Information

Patent NumberUS 11,857,258
TitleVergence recovery convalescence using dynamic vergence testing platform including 3D head mounted display system with integrated eye tracking technology
Assignee(s)NEUROLIGN USA, LLC